resiquimod has been researched along with mitomycin in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (mitomycin) | Trials (mitomycin) | Recent Studies (post-2010) (mitomycin) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 12,893 | 1,738 | 2,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, A; Al-Dhalimy, M; Bagby, GC; Chin, K; Garbati, MR; Hays, LE; Jillette, N; Newell, AE; Olson, SB; Rathbun, RK | 1 |
1 other study(ies) available for resiquimod and mitomycin
| Article | Year |
|---|---|
Cytokine overproduction and crosslinker hypersensitivity are unlinked in Fanconi anemia macrophages.
Topics: Animals; Cell Polarity; Cells, Cultured; Cross-Linking Reagents; DNA Damage; Fanconi Anemia; Fanconi Anemia Complementation Group C Protein; Histones; Humans; Imidazoles; Macrophages; Mice; Mitomycin; Reactive Oxygen Species; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2016 |